EP0116362A2 - Sterile package for therapeutic composition - Google Patents

Sterile package for therapeutic composition Download PDF

Info

Publication number
EP0116362A2
EP0116362A2 EP19840101187 EP84101187A EP0116362A2 EP 0116362 A2 EP0116362 A2 EP 0116362A2 EP 19840101187 EP19840101187 EP 19840101187 EP 84101187 A EP84101187 A EP 84101187A EP 0116362 A2 EP0116362 A2 EP 0116362A2
Authority
EP
European Patent Office
Prior art keywords
container
filter
composition
sterile
dilute
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19840101187
Other languages
German (de)
French (fr)
Other versions
EP0116362A3 (en
Inventor
Adrian R. Reti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EMD Millipore Corp
Original Assignee
Millipore Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millipore Corp filed Critical Millipore Corp
Publication of EP0116362A2 publication Critical patent/EP0116362A2/en
Publication of EP0116362A3 publication Critical patent/EP0116362A3/en
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1443—Containers with means for dispensing liquid medicaments in a filtered or sterile way, e.g. with bacterial filters
    • A61J1/145—Containers with means for dispensing liquid medicaments in a filtered or sterile way, e.g. with bacterial filters using air filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1443—Containers with means for dispensing liquid medicaments in a filtered or sterile way, e.g. with bacterial filters
    • A61J1/1456—Containers with means for dispensing liquid medicaments in a filtered or sterile way, e.g. with bacterial filters using liquid filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2027—Separating means having frangible parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed

Definitions

  • This invention relates to an apparatus for storing a sterile therapeutic preparation and for subsequently delivering the therapeutic preparation to a patient.
  • sterile concentrated therapeutic preparations Prior to the present invention, sterile concentrated therapeutic preparations have been stored in a hermetically sealed container, typically a thermoplastic, flexible, transparent container. It is desirable to utilize a system including a sterile package containing a concentrate which is subsequently to be diluted just prior to administration in order to avoid the cost and other disadvantages of storing and shipping large volumes and weights of water.
  • the concentrated therapeutic preparations are admixed with a sterile liquid such as sterile and pyrogen-free water or saline, which accounts for most of the weight and bulk of the final product.
  • Typical concentrated compositions which are packaged and subsequently administered to a patient in this manner include intravenous solutions, peritoneal dialysis solutions, irrigation solutions or the like which contain for example amino acids, sugars such as dextrose or glucose, minerals including electrolytes, vitamins or mixtures thereof.
  • the connecting means between the source of the diluting liquid and the receptacle containing the concentrate has always been associated with a relatively high risk of contamination. This is due primarily to the fact that during connection of the source of pyrogen-free diluting liquid to the container, the contents of the container are exposed to the atmosphere and the connector elements are exposed to the external environment which can lead to non-sterile conditions within the container.
  • no means are provided for alerting the user of the container of a change in sterile conditions within the container after its contents are diluted. concentrates, no means are diluted.
  • a package for a concentrated composition adapted to be diluted and subsequently administered to a patient which package includes a container for the concentrated composition, an inlet means for the package which includes a sterilizing filter integrally formed therewith and an outlet means which permits delivery of the diluted composition to the patient.
  • the concentrate is introduced into or formed within the package and the package and concentrate then are sterilized by any convenient means while the interior of the package and the concentrate are sealed_from the outside atmosphere.
  • sterilized and pyrogen-free dilution liquid is introduced into the package through the sterilizing filter, and the flow path downstream of the filter can then be sealed. Thereafter the diluted composition is removed from the package for administration to the patient through the outlet.
  • the concentrated composition and the interior of the container are sterilized in order to render them free of microorganisms.
  • the concentrated composition is introduced into the container and thereafter the container contents as well as the container interior are sterilized such as with ionizing radiation, ethylene oxide or heat.
  • the container is formed of a flexible transparent plastic composition which is moisture proof and impermeable to microorganisms. Suitable polymeric materials include polyvinyl chloride, polyethylene, polypropylene, polyethylene terphthalate or the like.
  • the contents of the container can be introduced therein by any convenient means such as by forming the container about the concentrated composition or by introducing the concentrated composition through an opening which subsequently serves as the outlet for the diluted composition or by any other convenient means.
  • the concentrated composition can be sealed, under sterile conditions, within a pod having a frangible portion which permits removal of the concentrated composition from the pod into the interior of the container so that it can be admixed with diluting liquid within the container.
  • the container must be provided with an inlet means which includes a sterile filter integrally formed therewith and which is positioned so that any diluting liquid subsequently introduced into the container must pass through the filter before entering the container so that the filter retains pyrogens and microorganisms.
  • This filter is formed intergrately with the container so that the entire structure of this invention is of unitary structure.
  • the container of this invention 10 includes a flexible plastic bag 12, an inlet 14 and an outlet 16.
  • the bag 12 contains the concentrate composition 18 which, together with the interior of the bag 12, is presterilized so that the bag contents are pyrogen-free and free of microorganisms.
  • a gas such as ethylene oxide
  • the gas can be introduced through inlet 14 or through outlet 16 prior to sealing it with seal 20.
  • the seal 20 can be made prior to sterilization.
  • the outlet 16 also includes a seal 20 in order to prevent intrusion of the outside atmosphere into the bag 12 after sterilization.
  • the inlet 14 includes a microporous filter 22, suitably supported within a housing 24 which microporous filter 22 prevents passage of microorganisms or pyrogen therethrough.
  • a suitable filter construction for example, is marketed by Millipore Corporation under the trademark, Millex R.
  • the conduit 26 to the filter housing is designed to permit passage of diluting liquid through the filter 22 and into the bag 12 in order to dilute the concentrated composition 18.
  • a frangible seal 27 may be provided to keep the concentrate 18 from leaking back through filter 22.
  • the bag 12 is provided with an inlet 14 which in turn is connected to a filter holder 24 that includes a supported filter 22 and to which is attached conduit 26.
  • the interior of the bag 12 is presterilized as is the pod 28 which contains the concentrate.
  • the pod 28 can be made of any conveniently frangible material which does not contaminate the concentrate such as polypropylene, polyethylene, or other thermoplastic polymer.
  • the pod can be easily be broken at either neck 30 and/or 32 by manually grasping the knobs 34 or 36 indirectly from the outside of the bag 12.
  • the bag 12 also is provided with an outlet 16 which contains a seal 20.
  • the inlet 26 can be provided with a seal 38 such as a heat seal in order to provide further protection against contamination of the contents of the bag 12 prior to administering the contents to a patient.
  • the seal 38 is adapted to be opened under the force of incoming diluting liquid to the bag 12 without rupturing the walls of inlet 26.
  • Diluent liquid is passed into plastic bag portion through conduit 37, filter 22 and inlet 26 when three-way valve 40 is open to permit communication between conduit 38 and inlet 26 while valve 42 is closed.
  • valve 4 0 is positioned to permit pressurized gas to pass from conduit 46 into conduit 44 when valve 42 is open.
  • a pressure sensor 47 is provided to monitor pressure. Gas pressure in conduit 44 and on filter 22 is controlled so that gas does not penetrate the inlet filter 22 because of surface tension effects when conduit 46 and conduit 44 are in communication. The pressurized gas displaces the liquid in conduit 44 and inlet 14.
  • valve 42 then is shut off while preventing communication between conduit 37 and either conduit 46 or conduit 44.
  • the gas pressure decay then is monitored by means of pressure sensor 47. If the pressure decay rate is small, the filter 22 is intact. If the pressure decay rate is high, the filter 22 has a leak or fluid bypass exists.
  • the three-way valve 40 then is closed and conduit 44 is disconnected from the housing for filter 22.

Abstract

O A sterile package for concentrated compositions is provided which composition is adapted to be diluted under sterile conditions for subsequent administration to a patient. The package is provided with an outlet and an inlet having a filter integrally formed therewith which retains pyrogen and microorganisms so that diluting liquid can be introduced into the package without contaminating the package contents.

Description

    BACKGROUND OF THE INVENTION
  • This invention relates to an apparatus for storing a sterile therapeutic preparation and for subsequently delivering the therapeutic preparation to a patient.
  • Prior to the present invention, sterile concentrated therapeutic preparations have been stored in a hermetically sealed container, typically a thermoplastic, flexible, transparent container. It is desirable to utilize a system including a sterile package containing a concentrate which is subsequently to be diluted just prior to administration in order to avoid the cost and other disadvantages of storing and shipping large volumes and weights of water. The concentrated therapeutic preparations are admixed with a sterile liquid such as sterile and pyrogen-free water or saline, which accounts for most of the weight and bulk of the final product. Typical concentrated compositions which are packaged and subsequently administered to a patient in this manner include intravenous solutions, peritoneal dialysis solutions, irrigation solutions or the like which contain for example amino acids, sugars such as dextrose or glucose, minerals including electrolytes, vitamins or mixtures thereof. The connecting means between the source of the diluting liquid and the receptacle containing the concentrate has always been associated with a relatively high risk of contamination. This is due primarily to the fact that during connection of the source of pyrogen-free diluting liquid to the container, the contents of the container are exposed to the atmosphere and the connector elements are exposed to the external environment which can lead to non-sterile conditions within the container. Unfortunately, when utilizing presently available containers for such concentrates, no means are provided for alerting the user of the container of a change in sterile conditions within the container after its contents are diluted.
    concentrates, no means are diluted.
  • It would be desirable to provide a packaging means for concentrate compositions which are subsequently diluted and administered to a patient which means assures that the concentrate does not become contaminated during the dilution step. Furthermore, it would be desirable to provide such a package which is applicable for a wide variety of concentrate compositions including solid compositions or liquid compositions.
    • SUMMARY OF THE INVENTION
  • In accordance with this invention, a package for a concentrated composition adapted to be diluted and subsequently administered to a patient is provided which package includes a container for the concentrated composition, an inlet means for the package which includes a sterilizing filter integrally formed therewith and an outlet means which permits delivery of the diluted composition to the patient. The concentrate is introduced into or formed within the package and the package and concentrate then are sterilized by any convenient means while the interior of the package and the concentrate are sealed_from the outside atmosphere. When the concentrate is to be diluted prior to administration, sterilized and pyrogen-free dilution liquid is introduced into the package through the sterilizing filter, and the flow path downstream of the filter can then be sealed. Thereafter the diluted composition is removed from the package for administration to the patient through the outlet.
    • BRIEF DESCRIPTION OF THE DRAWINGS
    • Fig. 1 is a side view of the package of this invention containing concentrate.
    • Fig. 2 is a side view of the package of this invention containing a pod which in turn contains concentrate.
    • Fig. 3 is a alternative structure of the inlet used with the package of this invention.
    • Fig. 4 illustrates means for testing the integrity for the sterilizing filter on the package of this invention.
    DESCRIPTION OF SPECIFIC EMBODIMENTS
  • The concentrated composition and the interior of the container are sterilized in order to render them free of microorganisms. The concentrated composition is introduced into the container and thereafter the container contents as well as the container interior are sterilized such as with ionizing radiation, ethylene oxide or heat. The container is formed of a flexible transparent plastic composition which is moisture proof and impermeable to microorganisms. Suitable polymeric materials include polyvinyl chloride, polyethylene, polypropylene, polyethylene terphthalate or the like. The contents of the container can be introduced therein by any convenient means such as by forming the container about the concentrated composition or by introducing the concentrated composition through an opening which subsequently serves as the outlet for the diluted composition or by any other convenient means. In one embodiment of this invention, the concentrated composition can be sealed, under sterile conditions, within a pod having a frangible portion which permits removal of the concentrated composition from the pod into the interior of the container so that it can be admixed with diluting liquid within the container.
  • Regardless of the method for filling the container or for sterilizing the container and its contents, the container must be provided with an inlet means which includes a sterile filter integrally formed therewith and which is positioned so that any diluting liquid subsequently introduced into the container must pass through the filter before entering the container so that the filter retains pyrogens and microorganisms. This filter is formed intergrately with the container so that the entire structure of this invention is of unitary structure.
  • Referring to Figure 1, the container of this invention 10 includes a flexible plastic bag 12, an inlet 14 and an outlet 16. The bag 12 contains the concentrate composition 18 which, together with the interior of the bag 12, is presterilized so that the bag contents are pyrogen-free and free of microorganisms. When sterilization is effected with a gas such as ethylene oxide, the gas can be introduced through inlet 14 or through outlet 16 prior to sealing it with seal 20. When utilizing sterilizing radiation, the seal 20 can be made prior to sterilization. The outlet 16 also includes a seal 20 in order to prevent intrusion of the outside atmosphere into the bag 12 after sterilization. The inlet 14 includes a microporous filter 22, suitably supported within a housing 24 which microporous filter 22 prevents passage of microorganisms or pyrogen therethrough. A suitable filter construction, for example, is marketed by Millipore Corporation under the trademark, MillexR. The conduit 26 to the filter housing is designed to permit passage of diluting liquid through the filter 22 and into the bag 12 in order to dilute the concentrated composition 18. A frangible seal 27 may be provided to keep the concentrate 18 from leaking back through filter 22.
  • Referring to Figure 2, the bag 12 is provided with an inlet 14 which in turn is connected to a filter holder 24 that includes a supported filter 22 and to which is attached conduit 26. The interior of the bag 12 is presterilized as is the pod 28 which contains the concentrate. The pod 28 can be made of any conveniently frangible material which does not contaminate the concentrate such as polypropylene, polyethylene, or other thermoplastic polymer. The pod can be easily be broken at either neck 30 and/or 32 by manually grasping the knobs 34 or 36 indirectly from the outside of the bag 12. The bag 12 also is provided with an outlet 16 which contains a seal 20.
  • Referring to Figure 3, in one aspect of this invention, the inlet 26 can be provided with a seal 38 such as a heat seal in order to provide further protection against contamination of the contents of the bag 12 prior to administering the contents to a patient. The seal 38 is adapted to be opened under the force of incoming diluting liquid to the bag 12 without rupturing the walls of inlet 26.
  • Referring to Figure 4, means for testing the integrity and sterility of the sterile package of this invention after dilution is shown. Diluent liquid is passed into plastic bag portion through conduit 37, filter 22 and inlet 26 when three-way valve 40 is open to permit communication between conduit 38 and inlet 26 while valve 42 is closed. When the bag 12 is filled with diluent liquid to the desired level, valve 40 is positioned to permit pressurized gas to pass from conduit 46 into conduit 44 when valve 42 is open. A pressure sensor 47 is provided to monitor pressure. Gas pressure in conduit 44 and on filter 22 is controlled so that gas does not penetrate the inlet filter 22 because of surface tension effects when conduit 46 and conduit 44 are in communication. The pressurized gas displaces the liquid in conduit 44 and inlet 14. The valve 42 then is shut off while preventing communication between conduit 37 and either conduit 46 or conduit 44. The gas pressure decay then is monitored by means of pressure sensor 47. If the pressure decay rate is small, the filter 22 is intact. If the pressure decay rate is high, the filter 22 has a leak or fluid bypass exists. The three-way valve 40 then is closed and conduit 44 is disconnected from the housing for filter 22.

Claims (9)

1. An article of manufacture comprising a moisture-proof, hermetically sealed container having an inlet and a hermetically sealed outlet, a sterile composition sealed within said container, a filter integrally formed with said inlet, said filter adapted to pass liquid into said container to dilute said composition while retaining pyrogen and microorganisms, the interior of said container and contents within said container being sterile and pyrogen-free.
2. An article of manufacture comprising a moisture-proof, hermetically sealed first container having an inlet and a hermetically sealed outlet, a second container sealed within said first container, a sterile composition sealed within said second container, said second container having a frangible portion adapted to permit removal of said composition from said second container into said first container, a filter integrally formed with said inlet, said filter adapted to pass liquid into said first container to dilute said composition while retaining pyrogen and microorganisms.
3. The article of manufacture of any one of claims 1 or 2 wherein said hermetically sealed container is formed from a transparent polymeric sheet.
4. The article of manufacture of any one of claims 1 or 3 wherein said inlet is sealed with a frangible seal between said filter and said hermetically sealed container.
5. The article of manufacture of either one of claims 1 or 2 including means for testing the integrity of said filter.
6. The article of manufacture of any one of claims 1 or 2 wherein said inlet is adapted to be connected with means for testing the integrity of said filter.
7. The process for providing a sterile liquid composition suitable for administration to a patient which comprises passing a pharmaceutically acceptable diluting liquid through said filter into the hermetically sealed, container of claim 1 to dilute said sterile composition to form a dilute sterile composition and passing said dilute sterile composition through said outlet to said patient under sterile conditions.
8. The process for providing a sterile liquid composition suitable for administration to a patient from the article of manufacture of claim 2 which comprises breaking the frangible portion of the second container to expose the sterile composition to the interior of the first container, passing a pharmaceutically acceptable diluting liquid through said filter into the hermetically sealed first container to dilute said sterile composition to form a dilute sterile composition and passing said dilute sterile composition through said outlet to said patient under sterile conditions.
9. The process of any one of claims 1 or 2 which include the step of testing the integrity of said filter subsequent to forming said dilute sterile composition.
EP19840101187 1983-02-11 1984-02-06 Sterile package for therapeutic composition Withdrawn EP0116362A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46572083A 1983-02-11 1983-02-11
US465720 1983-02-11

Publications (2)

Publication Number Publication Date
EP0116362A2 true EP0116362A2 (en) 1984-08-22
EP0116362A3 EP0116362A3 (en) 1985-05-15

Family

ID=23848908

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19840101187 Withdrawn EP0116362A3 (en) 1983-02-11 1984-02-06 Sterile package for therapeutic composition

Country Status (1)

Country Link
EP (1) EP0116362A3 (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001135A1 (en) * 1989-07-17 1991-02-07 Kabivitrum Ab A nutritive composition and a method for its preparation
EP0545000A1 (en) * 1991-12-05 1993-06-09 Victor Grifols Lucas An improved vessel for perfusion liquids
EP0696448A2 (en) * 1994-08-09 1996-02-14 Material Engineering Technology Laboratory, Inc. A liquid container for dispensing medical solutions
EP1352663A2 (en) * 2002-04-12 2003-10-15 Hyclone Laboratories, Inc. Systems for forming sterile fluid connections and methods of use
EP1437115A1 (en) * 2001-09-14 2004-07-14 Nipro Corporation Chemical feeding port and chemical container with the port
EP2765971A4 (en) * 2011-10-11 2015-06-17 Soinial Ab Bag and method for intravenous or intracorporeal administration of medical solution to a patient
US9289522B2 (en) 2012-02-28 2016-03-22 Life Technologies Corporation Systems and containers for sterilizing a fluid
WO2019018200A1 (en) * 2017-07-17 2019-01-24 Baxter International Inc. Medical product including pre-filled product bag
US10617603B2 (en) 2016-01-22 2020-04-14 Baxter International Inc. Sterile solutions product bag
US11021275B2 (en) 2016-01-22 2021-06-01 Baxter International Inc. Method and machine for producing sterile solution product bags

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2817337A (en) * 1953-11-12 1957-12-24 Pablo T Herzig Filtering device for the innocuous preparation of injectable solutions
US3255923A (en) * 1964-02-03 1966-06-14 Lacto Seal Inc Disposable liquid storage and dispensing device
GB2052948A (en) * 1979-06-22 1981-02-04 Biotest Serum Institut Gmbh Apparatus for conserving blood or plasma
FR2465657A1 (en) * 1979-09-19 1981-03-27 Gerda Sa Laboratoires Dry foodstuff contg. plastics bag - provided for tubes for introducing water and discharging soln. or dispersion of contents
WO1981001248A1 (en) * 1979-11-01 1981-05-14 Baxter Travenol Lab Process and apparatus for transferring and sterilizing a solution

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2817337A (en) * 1953-11-12 1957-12-24 Pablo T Herzig Filtering device for the innocuous preparation of injectable solutions
US3255923A (en) * 1964-02-03 1966-06-14 Lacto Seal Inc Disposable liquid storage and dispensing device
GB2052948A (en) * 1979-06-22 1981-02-04 Biotest Serum Institut Gmbh Apparatus for conserving blood or plasma
FR2465657A1 (en) * 1979-09-19 1981-03-27 Gerda Sa Laboratoires Dry foodstuff contg. plastics bag - provided for tubes for introducing water and discharging soln. or dispersion of contents
WO1981001248A1 (en) * 1979-11-01 1981-05-14 Baxter Travenol Lab Process and apparatus for transferring and sterilizing a solution

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991001135A1 (en) * 1989-07-17 1991-02-07 Kabivitrum Ab A nutritive composition and a method for its preparation
EP0545000A1 (en) * 1991-12-05 1993-06-09 Victor Grifols Lucas An improved vessel for perfusion liquids
EP0696448A2 (en) * 1994-08-09 1996-02-14 Material Engineering Technology Laboratory, Inc. A liquid container for dispensing medical solutions
JPH0852196A (en) * 1994-08-09 1996-02-27 Material Eng Tech Lab Inc Transfusion container having connecting port for medicine
EP0696448A3 (en) * 1994-08-09 1996-05-01 Shinsozai Sogo Kenkyusho Kk A liquid container for dispensing medical solutions
US5662642A (en) * 1994-08-09 1997-09-02 Material Engineering Technology Laboratory, Inc. Instillator with medicator-connecting mouth
US7322969B2 (en) 2001-09-14 2008-01-29 Nipro Corporation Liquid-medicine injection port device, and liquid-medicine container provided with the same
EP1437115A1 (en) * 2001-09-14 2004-07-14 Nipro Corporation Chemical feeding port and chemical container with the port
EP1437115A4 (en) * 2001-09-14 2006-11-29 Nipro Corp Chemical feeding port and chemical container with the port
EP1352663A3 (en) * 2002-04-12 2005-10-12 Hyclone Laboratories, Inc. Systems for forming sterile fluid connections and methods of use
EP1352663A2 (en) * 2002-04-12 2003-10-15 Hyclone Laboratories, Inc. Systems for forming sterile fluid connections and methods of use
EP2765971A4 (en) * 2011-10-11 2015-06-17 Soinial Ab Bag and method for intravenous or intracorporeal administration of medical solution to a patient
US9737624B2 (en) 2012-02-28 2017-08-22 Life Technologies Corporation Systems and containers for sterilzing a fluid
US9289522B2 (en) 2012-02-28 2016-03-22 Life Technologies Corporation Systems and containers for sterilizing a fluid
US10166306B2 (en) 2012-02-28 2019-01-01 Life Technologies Corporation Containers and systems for processing a fluid
US10821197B2 (en) 2012-02-28 2020-11-03 Life Technologies Corporation Containers and systems for processing a fluid
US11833259B2 (en) 2012-02-28 2023-12-05 Life Technologies Corporation Containers and systems for processing a fluid
US10617603B2 (en) 2016-01-22 2020-04-14 Baxter International Inc. Sterile solutions product bag
US11021275B2 (en) 2016-01-22 2021-06-01 Baxter International Inc. Method and machine for producing sterile solution product bags
US11564867B2 (en) 2016-01-22 2023-01-31 Baxter International Inc. Sterile solutions product bag
US11623773B2 (en) 2016-01-22 2023-04-11 Baxter International Inc. Method and machine for producing sterile solution product bags
WO2019018200A1 (en) * 2017-07-17 2019-01-24 Baxter International Inc. Medical product including pre-filled product bag

Also Published As

Publication number Publication date
EP0116362A3 (en) 1985-05-15

Similar Documents

Publication Publication Date Title
US4467588A (en) Separated packaging and sterile processing for liquid-powder mixing
US5368586A (en) Closure for a drug-vial
EP0393174B1 (en) Cell culture media flexible container
CA1234369A (en) Closed drug delivery system
CA1237028A (en) Multiple chamber container having leak detection compartment
US3554256A (en) Flexible intravenous container
US6893428B2 (en) Over-wrap bag enclosure for sterile connectors
CA1152026A (en) Package
EP1937202B1 (en) Dual-chamber solution packaging system
US5259844A (en) Flexible container
EP0116362A2 (en) Sterile package for therapeutic composition
JP2010013188A (en) Bag for storing and transporting sterile product in powder form and producing solution of the product therein
EP0412134A4 (en) Closure and port assembly
CN114246794A (en) Nutrient substance device
GB2117733A (en) Sterilized liquid mixing system
WO2019111938A1 (en) Port-equipped bag and cap-equipped bag
US20200130873A1 (en) Methods for preparing autologous blood eye drops
CA2174508A1 (en) Method of sterilizing prefilled syringe medicines
JP4335334B2 (en) Drug infusion container
JPS6312634B2 (en)
EP0750488B1 (en) A device and a process for aseptic mixing of liquid products
EP0508251A1 (en) Admixture container for connecting a syringe and method
WO2002041824A2 (en) Over-wrap bag enclosure for sterile connectors
JPH0595987A (en) Drug feeding package for medical use
JPH1085306A (en) Container for medical care

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Designated state(s): CH DE FR GB LI NL SE

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Designated state(s): CH DE FR GB LI NL SE

17P Request for examination filed

Effective date: 19850620

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19860829

RIN1 Information on inventor provided before grant (corrected)

Inventor name: RETI, ADRIAN R.